These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 15068834

  • 1. Effects of low dose aspirin (81 mg) on proliferating cell nuclear antigen and Amaranthus caudatus labeling in normal-risk and high-risk human subjects for colorectal cancer.
    Krishnan K, Aoki T, Ruffin MT, Normolle DP, Boland CR, Brenner DE.
    Cancer Detect Prev; 2004; 28(2):107-13. PubMed ID: 15068834
    [Abstract] [Full Text] [Related]

  • 2. Comparison of proliferating cell nuclear antigen versus the more standard measures of rectal mucosal proliferation rates in subjects with a history of colorectal cancer and normal age-matched controls.
    Einspahr J, Alberts D, Xie T, Ritchie J, Earnest D, Hixson L, Powell M, Roe D, Grogan T.
    Cancer Epidemiol Biomarkers Prev; 1995 Jun; 4(4):359-66. PubMed ID: 7655331
    [Abstract] [Full Text] [Related]

  • 3. Use of the lectin from Amaranthus caudatus as a histochemical probe of proliferating colonic epithelial cells.
    Boland CR, Chen YF, Rinderle SJ, Resau JH, Luk GD, Lynch HT, Goldstein IJ.
    Cancer Res; 1991 Jan 15; 51(2):657-65. PubMed ID: 1985783
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of incubation of rectal biopsies on measures of proliferation using proliferating cell nuclear antigen in comparison with 5-bromo-2-deoxyuridine.
    Kilias D, Macrae FA, Sharpe K, Young GP.
    Cancer Epidemiol Biomarkers Prev; 1997 Oct 15; 6(10):819-24. PubMed ID: 9332765
    [Abstract] [Full Text] [Related]

  • 6. Methodological findings and considerations in measuring colorectal epithelial cell proliferation in humans.
    Bostick RM, Fosdick L, Lillemoe TJ, Overn P, Wood JR, Grambsch P, Elmer P, Potter JD.
    Cancer Epidemiol Biomarkers Prev; 1997 Nov 15; 6(11):931-42. PubMed ID: 9367067
    [Abstract] [Full Text] [Related]

  • 7. Comparison of rectal mucosal proliferation measured by proliferating cell nuclear antigen (PCNA) immunohistochemistry and whole crypt dissection.
    Murray SC, Sandler RS, Keku TO, Lyles CM, Millikan RC, Bangdiwala SI, Kupper LL, Jiang W, Ulshen MH.
    Cancer Epidemiol Biomarkers Prev; 1995 Nov 15; 4(7):715-20. PubMed ID: 8672987
    [Abstract] [Full Text] [Related]

  • 8. Reliability of rectal epithelial kinetic patterns as an intermediate biomarker of colon cancer.
    Anti M, Marra G, Percesepe A, Armelao F, Gasbarrini G.
    J Cell Biochem Suppl; 1994 Nov 15; 19():68-75. PubMed ID: 7823608
    [Abstract] [Full Text] [Related]

  • 9. Effects of sodium selenite on deoxycholic acid-induced hyperproliferation of human colonic mucosa in short-term culture.
    Bartram HP, Draenert R, Dusel G, Richter F, Liebscher E, Christl SU, Scheppach W, Kasper H.
    Cancer Epidemiol Biomarkers Prev; 1998 Dec 15; 7(12):1085-9. PubMed ID: 9865426
    [Abstract] [Full Text] [Related]

  • 10. Colon cancer chemoprevention: clinical development of aspirin as a chemopreventive agent.
    Krishnan K, Ruffin MT, Brenner DE.
    J Cell Biochem Suppl; 1997 Dec 15; 28-29():148-58. PubMed ID: 9589361
    [Abstract] [Full Text] [Related]

  • 11. Effect of aspirin on prostaglandin E2 formation and transforming growth factor alpha expression in human rectal mucosa from individuals with a history of adenomatous polyps of the colon.
    Barnes CJ, Hamby-Mason RL, Hardman WE, Cameron IL, Speeg KV, Lee M.
    Cancer Epidemiol Biomarkers Prev; 1999 Apr 15; 8(4 Pt 1):311-5. PubMed ID: 10207634
    [Abstract] [Full Text] [Related]

  • 12. Methodological problems in the use of rectal cell proliferation as a biomarker of colorectal cancer risk.
    Biasco G, Paganelli GM, Santucci R, Brandi G, Barbara L.
    J Cell Biochem Suppl; 1994 Apr 15; 19():55-60. PubMed ID: 7823606
    [Abstract] [Full Text] [Related]

  • 13. Oral cancer cells differ from normal oral epithelial cells in tissue like organization and in response to lycopene treatment: an organotypic cell culture study.
    Livny O, Kaplan I, Reifen R, Polak-Charcon S, Madar Z, Schwartz B.
    Nutr Cancer; 2003 Apr 15; 47(2):195-209. PubMed ID: 15087273
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Cyclosporine A inhibits colorectal cancer proliferation probably by regulating expression levels of c-Myc, p21(WAF1/CIP1) and proliferating cell nuclear antigen.
    Masuo T, Okamura S, Zhang Y, Mori M.
    Cancer Lett; 2009 Nov 18; 285(1):66-72. PubMed ID: 19481339
    [Abstract] [Full Text] [Related]

  • 16. Opposite effects on human colon cancer cell proliferation of two dietary Thomsen-Friedenreich antigen-binding lectins.
    Yu LG, Milton JD, Fernig DG, Rhodes JM.
    J Cell Physiol; 2001 Feb 18; 186(2):282-7. PubMed ID: 11169464
    [Abstract] [Full Text] [Related]

  • 17. Reproducibility and variability of the rectal mucosal proliferation index using proliferating cell nuclear antigen immunohistochemistry.
    Lyles CM, Sandler RS, Keku TO, Kupper LL, Millikan RC, Murray SC, Bangdiwala SI, Ulshen MH.
    Cancer Epidemiol Biomarkers Prev; 1994 Feb 18; 3(7):597-605. PubMed ID: 7827591
    [Abstract] [Full Text] [Related]

  • 18. Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States).
    Kim S, Baron JA, Mott LA, Burke CA, Church TR, McKeown-Eyssen GE, Cole BF, Haile RW, Sandler RS.
    Cancer Causes Control; 2006 Dec 18; 17(10):1299-304. PubMed ID: 17111262
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of epithelial cell proliferation rate in normal-appearing colonic mucosa as a high-risk marker for colorectal cancer.
    Akedo I, Ishikawa H, Ioka T, Kaji I, Narahara H, Ishiguro S, Suzuki T, Otani T.
    Cancer Epidemiol Biomarkers Prev; 2001 Sep 18; 10(9):925-30. PubMed ID: 11535542
    [Abstract] [Full Text] [Related]

  • 20. Proliferating-cell nuclear antigen (PCNA) as an independent prognostic marker in patients after prostatectomy: a comparison of PCNA and Ki-67.
    Taftachi R, Ayhan A, Ekici S, Ergen A, Ozen H.
    BJU Int; 2005 Mar 18; 95(4):650-4. PubMed ID: 15705097
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.